These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2779236)

  • 1. Heterogeneity of [3H]estradiol binding sites in the rat prostate: properties and distribution of type I and type II sites.
    Yu M; Cates J; Leav I; Ho SM
    J Steroid Biochem; 1989 Sep; 33(3):449-57. PubMed ID: 2779236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
    Ho SM; Yu M
    J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen dependent induction of low affinity binding sites in the nuclear fraction of rat uterus.
    De Hertogh R; Ekka E; Vanderheyden I
    J Steroid Biochem; 1986 Jun; 24(6):1171-7. PubMed ID: 3736044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic cytosol binding of 5 alpha-androstane-3 beta, 17 beta-diol and estradiol-17 beta.
    Ho SM; Ofner P
    Steroids; 1986 Jan; 47(1):21-34. PubMed ID: 3810696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear acceptor sites for estrogen-receptor complexes in the liver of the turtle, Chrysemys picta. I. Sexual differences, species specificity and hormonal dependency.
    Yu MS; Ho SM
    Mol Cell Endocrinol; 1989 Jan; 61(1):37-48. PubMed ID: 2744216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity and distribution of estrogen binding sites in guinea pig seminal vesicle.
    Weinberger MJ
    J Steroid Biochem; 1984 Jun; 20(6A):1327-32. PubMed ID: 6748647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
    Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
    Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibition of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
    Ho SM; Viccione T; Yu M
    J Steroid Biochem Mol Biol; 1993 Oct; 46(4):489-95. PubMed ID: 8217879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary assessment of luteolin as an affinity ligand for type II estrogen--binding sites in rat uterine nuclear extracts.
    Markaverich BM; Gregory RR
    Steroids; 1993 Jun; 58(6):268-74. PubMed ID: 8212072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitative distribution of cytosolic androgen receptors in microdissected areas of the male rat brain: effects of estrogen treatment.
    Handa RJ; Roselli CE; Horton L; Resko JA
    Endocrinology; 1987 Jul; 121(1):233-40. PubMed ID: 3496208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.
    Markaverich BM; Roberts RR; Alejandro MA; Johnson GA; Middleditch BS; Clark JH
    J Steroid Biochem; 1988; 30(1-6):71-8. PubMed ID: 3386279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogen-binding proteins in the rat ventral prostate: specific and nonspecific high-affinity binding sites for benzo(a)pyrene, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Söderkvist P; Poellinger L; Gustafsson JA
    Cancer Res; 1986 Feb; 46(2):651-7. PubMed ID: 3940634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.
    Markaverich BM; Roberts RR; Finney RW; Clark JH
    J Biol Chem; 1983 Oct; 258(19):11663-71. PubMed ID: 6619136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of oestradiol to guinea-pig prostate cytosol and nuclear fractions.
    Tilley WD; Horsfall DJ; Cant EL; Marshall VR
    J Steroid Biochem; 1985 Jun; 22(6):705-11. PubMed ID: 4021477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estradiol-17 beta and estriol on their binding sites in the rabbit uterus.
    Tamaya T; Kawabata I; Iida K; Imai A
    Comp Biochem Physiol B; 1990; 95(2):415-8. PubMed ID: 2328574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding sites for glucocorticoids in cytosols from the ventral prostate and seminal vesicle of rats.
    Noguchi T; Izawa M; Ichii S
    Endocrinol Jpn; 1983 Aug; 30(4):513-21. PubMed ID: 6671455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.